| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/17/2023 | Travere Therapeutics, Inc. | RTRX | Grant | | 13.5k | $17.11 | $231k | | 05/17/2023 |
| 05/17/2023 | Travere Therapeutics, Inc. | RTRX | Grant | | 4.5k | $0.00 | $0 | | 05/17/2023 |
| 01/18/2023 | Indaptus Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 100k | $1.61 | $161k | | 01/18/2023 |
| 11/21/2022 | Indaptus Therapeutics, Inc. | | Purchase | Common stock | 9.6k | $1.90 | $18.2k | | 11/18/2022 |
| 11/18/2022 | Indaptus Therapeutics, Inc. | | Purchase | Common stock | 400 | $1.76 | $705.5 | | 11/18/2022 |
| 09/08/2022 | Indaptus Therapeutics, Inc. | | Purchase | Common stock | 10.3k | $2.80 | $28.9k | | 09/08/2022 |
| 09/07/2022 | Indaptus Therapeutics, Inc. | | Purchase | Common stock | 8.6k | $2.57 | $22.2k | | 09/06/2022 |
| 09/06/2022 | Indaptus Therapeutics, Inc. | | Purchase | Common stock | 1.1k | $2.44 | $2.6k | | 09/06/2022 |
| 06/06/2022 | Indaptus Therapeutics, Inc. | | Purchase | Common stock | 19.7k | $2.63 | $51.9k | | 06/06/2022 |
| 05/11/2022 | Travere Therapeutics, Inc. | RTRX | Grant | | 3k | $0.00 | $0 | | 05/11/2022 |
| 05/11/2022 | Travere Therapeutics, Inc. | RTRX | Grant | | 9k | $21.38 | $192.4k | | 05/11/2022 |
| 01/26/2022 | Indaptus Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 200k | $4.90 | $980k | | 01/26/2022 |
| 11/18/2021 | Indaptus Therapeutics, Inc. | | Purchase | Common Stock | 11.2k | $5.82 | $65.1k | | 11/18/2021 |
| 09/14/2021 | Indaptus Therapeutics, Inc. | | Purchase | Common Stock | 12k | $7.00 | $84k | | 09/14/2021 |
| 08/04/2021 | Indaptus Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 375k | $8.87 | $3.3M | | 08/04/2021 |
| 05/14/2021 | Travere Therapeutics, Inc. | RTRX | Grant | | 3k | $0.00 | $0 | | 05/14/2021 |
| 05/14/2021 | Travere Therapeutics, Inc. | RTRX | Grant | | 9k | $18.27 | $164.4k | | 05/14/2021 |
| 07/15/2020 | Intec Pharma Ltd. | NTEC | Grant | Stock Option (right to buy) | 300k | $0.31 | $92.2k | | 07/15/2020 |
| 05/15/2020 | Travere Therapeutics, Inc. | RTRX | Grant | Employee stock option (right to buy) | 9k | $15.43 | $138.9k | | 05/15/2020 |
| 05/15/2020 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 3k | $0.00 | $0 | | 05/15/2020 |
| 08/28/2019 | Intec Pharma Ltd. | NTEC | Purchase | Ordinary Shares | 20k | $0.68 | $13.6k | | 08/28/2019 |
| 08/23/2019 | Intec Pharma Ltd. | NTEC | Purchase | Ordinary Shares | 100k | $0.46 | $45.7k | | 08/23/2019 |
| 05/08/2019 | Travere Therapeutics, Inc. | RTRX | Grant | Employee stock option (right to buy) | 8k | $17.94 | $143.5k | | 05/08/2019 |
| 05/08/2019 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 2k | $0.00 | $0 | | 05/08/2019 |
| 04/04/2019 | Intec Pharma Ltd. | NTEC | Grant | Stock Option (right to buy) | 125k | $7.64 | $955k | | 04/04/2019 |
| 05/09/2018 | Travere Therapeutics, Inc. | RTRX | Grant | Common Stock | 2.5k | $0.00 | $0 | | 05/09/2018 |
| 05/09/2018 | Travere Therapeutics, Inc. | RTRX | Grant | Employee Stock Option (Right to Buy) | 10k | $26.52 | $265.2k | | 05/09/2018 |
| 05/03/2013 | NOVELION THERAPEUTICS INC. | NVLNF | Purchase | Common Stock | 20k | $7.96 | $159.2k | | 05/03/2013 |